Living Donor Liver Transplants For Sick Recipients During Covid-19 Pandemic-An Experience From A Tertiary Center In India

AMERICAN JOURNAL OF TRANSPLANTATION(2020)

引用 8|浏览3
暂无评分
摘要
The recent outbreak of COVID-19 has brought elective surgeries including liver transplantation to a standstill. The concerns in Living Donor Liver Transplant (LDLT) were that immunosuppressed recipients and healthy donors would be exposed to nosocomial SARS- CoV-2 infection.1 However, as patients began to suffer and die, Liver Transplant Society of India (LTSI) revised its guidelines 2 and allowed LDLT for those who were very sick, or had just recovered from a life threatening decompensation (high MELD/ CTP score) or had malignancy. Over 90 % of transplants in India are from live donors as we have a very low donation rate.
更多
查看译文
关键词
clinical research, practice, editorial, personal viewpoint, infection and infectious agents - viral, infectious disease, liver transplantation, hepatology, liver transplantation, living donor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要